SCHEMBL359447

SCHEMBL359447

Cc1ccc2c(c1)C(C)(C)c1cc(C)ccc1N2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.46
CYP1A2 P05177 2/20 0.46
POLB P06746 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPT P10636 3/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ROS1 P08922 1/20 0.41
CDK5 Q00535 1/20 0.41
ACVR1 Q04771 1/20 0.41
LRRK2 Q5S007 1/20 0.41
AKR1B1 P15121 1/20 0.41
THRB P10828 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31147116 1.00 CYP3A4 (0.46) CYP3A4CYP1A2POLBCYP2C19MAPT
SCHEMBL28267352 0.92 CYP1A2 (0.41) CYP3A4CYP1A2POLBCYP2C19MAPT
SCHEMBL19626168 0.90 PDK2 (0.50) CYP3A4CYP1A2POLBCYP2C19MAPT
SCHEMBL31605984 0.88 CYP1A2 (0.39) CYP3A4CYP1A2POLBCYP2C19MAPT
SCHEMBL29638497 0.85 CYP1A2 (0.35) CYP3A4CYP1A2POLBCYP2C19MAPT
SCHEMBL2265773 0.83 CYP1A2 (0.57) CYP3A4CYP1A2POLBCYP2C19AKR1B1
SCHEMBL31238639 0.83 CYP1A2 (0.57) CYP3A4CYP1A2POLBCYP2C19AKR1B1
SCHEMBL28510693 0.81 SMN1; SMN2 (0.41) CYP3A4CYP1A2POLBCYP2C19MAPT
SCHEMBL22902403 0.80 PDK2 (0.41) CYP3A4CYP1A2POLBCYP2C19MAPT
SCHEMBL31606058 0.80 PGR (0.40) MAPTALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116178430-A Acridine-based self-assembled hole selection material and preparation method and application thereof 南方科技大学 2023-05-30 CN disclosed
US-20230157163-A1 ORGANIC COMPOUND, PREPARATION METHOD THEREOF, AND DISPLAY PANEL WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2023-05-18 US disclosed
US-11545638-B2 Organic compound and manufacturing method thereof, and organic light emitting diode electroluminescent device WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2023-01-03 US disclosed
US-20220181552-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2022-06-09 US disclosed
US-20210193926-A1 THERMALLY ACTIVATED DELAYED FLUORESCENCE GREEN POLYMER MATERIAL AND PREPARATION METHOD THEREOF WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-06-24 US disclosed
WO-2021120450-A1 THERMALLY-ACTIVATED DELAYED FLUORESCENCE GREEN LIGHT POLYMER MATERIAL AND PREPARATION METHOD THEREFOR 武汉华星光电半导体显示技术有限公司 2021-06-24 WO disclosed
WO-2021103060-A1 HOLE TRANSPORT MATERIAL, PREPARATION METHOD THEREFOR, AND ORGANIC LIGHT EMITTING DEVICE 武汉华星光电半导体显示技术有限公司 2021-06-03 WO disclosed
US-20210020853-A1 ORGANIC COMPOUND AND MANUFACTURING METHOD THEREOF, AND ORGANIC LIGHT EMITTING DIODE ELECTROLUMINESCENT DEVICE WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-01-21 US disclosed
EP-3483159-B1 NITROGEN-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2020-12-09 EP disclosed
WO-2020238094-A1 EFFICIENT BLUE GREEN-TO-ORANGE RED LIGHT THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF 武汉华星光电半导体显示技术有限公司 2020-12-03 WO disclosed
EP-2896627-A1 Metals containing organic complexes Merck Patent GmbH (DE) 2015-07-22 EP disclosed
EP-2896627-A1 Metals containing organic complexes Merck Patent GmbH (DE) 2015-07-22 EP disclosed
EP-2593184-B1 METAL COMPLEXES WITH ORGANIC LIGANDS AND THE USE THEREOF IN OLEDS MERCK PATENT GMBH (DE) 2014-12-31 EP disclosed
EP-2593184-B1 METAL COMPLEXES WITH ORGANIC LIGANDS AND THE USE THEREOF IN OLEDS MERCK PATENT GMBH (DE) 2014-12-31 EP disclosed
EP-2593184-A1 METAL COMPLEXES WITH ORGANIC LIGANDS AND USE THEREOF IN OLEDS Merck Patent GmbH (DE) 2013-05-22 EP disclosed
US-20130116755-A1 METAL COMPLEXES WITH ORGANIC LIGANDS AND USE THEREOF IN OLEDS MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
US-20130116755-A1 METAL COMPLEXES WITH ORGANIC LIGANDS AND USE THEREOF IN OLEDS MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
US-20130116755-A1 METAL COMPLEXES WITH ORGANIC LIGANDS AND USE THEREOF IN OLEDS MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
WO-2012007103-A1 METAL COMPLEXES WITH ORGANIC LIGANDS AND USE THEREOF IN OLEDS MERCK PATENT GMBH (DE) 2012-01-19 WO disclosed
WO-2012007103-A1 METAL COMPLEXES WITH ORGANIC LIGANDS AND USE THEREOF IN OLEDS MERCK PATENT GMBH (DE) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157163-A1 ORGANIC COMPOUND, PREPARATION METHOD THEREOF, AND DISPLAY PANEL HTR4, AR, HTR2C CYP3A4 93/4885CYP1A2 81/4885POLB 3931/4885
US-20210193926-A1 THERMALLY ACTIVATED DELAYED FLUORESCENCE GREEN POLYMER MATERIAL AND PREPARATION METHOD THEREOF GFPT1, CD69, MAP1LC3A CYP3A4 2091/4885CYP1A2 4264/4885POLB 2434/4885
US-20220181552-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, EFNA1, EPCAM CYP3A4 630/4885CYP1A2 390/4885POLB 1651/4885
US-11545638-B2 Organic compound and manufacturing method thereof, and organic light emitting diode electroluminescent device HTT, ICMT, PORCN CYP3A4 429/4885CYP1A2 1184/4885POLB 1845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.